Astec Lifesciences Ltd
₹699.80
-2.24%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Promoters hold a majority stake (71.97%).
!Watch-points
- Higher leverage: debt-to-equity of 1.15 is above 1.
- Thin interest cover: operating profit covers interest only about -0.1 times.
- Return on equity is on the lower side at -25.2%.
- Return on capital employed is on the lower side at -5.4%.
- The company reported a net loss in the latest period.
- Sales growth has been slow over five years (about -4% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 1,559 Cr
Current Price₹ 699.80
High / Low₹ 941.75 / 513.40
Stock P/E—
Book Value₹ 175.00
Dividend Yield0%
ROCE-5.44%
ROE-25.20%
Face Value₹ 10.00
Debt to Equity1.15
PEG Ratio—
EV / EBITDA48.98
Industry PE22.25
P/B Ratio3.9920366
EPS₹ -36.32
Debt₹ 449 Cr
PAT Margin-18.08%
Cash PAT₹ -36 Cr
ICR-0.11
Promoter Holding71.97%
FII Holding0.01%
DII Holding3.33%
Public Holding24.69%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity